MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Karyopharm Therapeutics Inc

Fechado

SetorSaúde

4.36 -5.22

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.36

Máximo

4.74

Indicadores-chave

By Trading Economics

Rendimento

7.3M

-23M

Vendas

-527K

30M

EPS

-2.77

Margem de lucro

-78.168

Funcionários

279

EBITDA

-14M

-33M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+404.34% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-14M

38M

Abertura anterior

9.58

Fecho anterior

4.36

Sentimento de Notícias

By Acuity

50%

50%

157 / 375 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Karyopharm Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de jul. de 2025, 23:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3 de jul. de 2025, 23:42 UTC

Conversa de Mercado

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3 de jul. de 2025, 23:41 UTC

Conversa de Mercado

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3 de jul. de 2025, 23:41 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de jul. de 2025, 23:15 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3 de jul. de 2025, 22:59 UTC

Conversa de Mercado

Uranium Market About to Enter Lull -- Market Talk

3 de jul. de 2025, 22:58 UTC

Conversa de Mercado

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3 de jul. de 2025, 22:47 UTC

Conversa de Mercado

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3 de jul. de 2025, 22:21 UTC

Ganhos

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

3 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

3 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

3 de jul. de 2025, 20:41 UTC

Conversa de Mercado

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3 de jul. de 2025, 20:41 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de jul. de 2025, 19:28 UTC

Conversa de Mercado

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3 de jul. de 2025, 19:03 UTC

Conversa de Mercado

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3 de jul. de 2025, 18:34 UTC

Conversa de Mercado

Gold Has Winning Week, But Down Day -- Market Talk

3 de jul. de 2025, 18:18 UTC

Conversa de Mercado

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3 de jul. de 2025, 18:06 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

3 de jul. de 2025, 18:06 UTC

Conversa de Mercado

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3 de jul. de 2025, 17:27 UTC

Conversa de Mercado

U.S. Oil Rig Count Continues to Slide -- Market Talk

3 de jul. de 2025, 16:55 UTC

Ganhos

Travel Stocks Could Offer Investors a Glorious -2-

3 de jul. de 2025, 16:55 UTC

Ganhos

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3 de jul. de 2025, 16:20 UTC

Conversa de Mercado

Correction to Health Care Roundup: Market Talk

3 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

3 de jul. de 2025, 16:05 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de jul. de 2025, 16:05 UTC

Conversa de Mercado

Gold Futures Fall Following Jobs Report -- Market Talk

3 de jul. de 2025, 15:47 UTC

Ganhos

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3 de jul. de 2025, 15:36 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Comparação entre Pares

Variação de preço

Karyopharm Therapeutics Inc Previsão

Preço-alvo

By TipRanks

404.34% parte superior

Previsão para 12 meses

Média 23.25 USD  404.34%

Máximo 42 USD

Mínimo 8 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Karyopharm Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

5.9501 / 7.66Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

157 / 375 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$